Recommended Pages at cornell-lymphoma.com
Lymphoma in the News: Lenalidomide Plus Rituximab Shows Promise as First-Line Therapy in Patients with Indolent Non-Hodgkin Lymphoma « New Developments in Lymphoma
cornell-lymphoma.com — “Lymphoma in the News: Lenalidomide Plus Rituximab Shows Promise as First-Line Therapy in Patients with Indolent Non-Hodgkin Lymphoma « New Developments in Lymphoma” View full resource at cornell-lymphoma.com
Most Recently Shared on July 22, 2011 at 1:36 pm By:
Lenalidomide Plus Rituximab Shows Promise as First-Line Therapy in Patients with Indolent #Lymphoma http://t.co/NK7NvgG
